Non-Alcoholic Fatty Liver Disease, Diabetes Mellitus, and Zinc/ Zinc Transporters: Is there a Connection?
Reference65 articles.
1. Banini BA, Sanyal AJ. Nonalcoholic fatty liver disease: Epidemiology, pathogenesis, natural history, diagnosis, and current treatment options. Clinical Medicine Insights: Therapeutics. 2016;8:75-84
2. Roeb E, Steffen HM, Bantel H, et al. S2 k-Leitlinie nicht alkoholische Fettlebererkrankungen. Zeitschrift für Gastroenterologie. 2015;53:668-723
3. Roeb E, Steffen MH, Bojunga J. S2 k-Leitlinie Nicht-alkoholische Fettlebererkrankungen—Was gibt’s Neues? Deutsche Medizinische Wochenschrift. 2016;141:494-496
4. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nature Reviews. Gastroenterology & Hepatology. 2013;10(11):656-665
5. Tilg H, Moschen AR. Evolution of inflammation in non-alcoholic-fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836-1846